论文部分内容阅读
目的:比较静脉药物配制中心(PIVAS)建立前后医嘱单静脉用药的合理性。方法:选取PIVAS建立前(2013年1—12月)静脉用药长期医嘱单为A组,PIVAS建立后(2015年1—12月)静脉用药长期医嘱单为B组,分析医嘱单用药不合理缺陷的原因,干预临床不合理用药医嘱,促使临床合理用药。结果:A组有117 381组(每瓶输液为1组)医嘱存在用药不合理现象占20.67%;B组有45 147组占8.06%,药师分析后事前做了干预,纠正率由25.05%提高到94.78%。结论:PIVAS药师在医嘱未执行前对其审核,并采取多种干预方式干预,有效制止了不合理用药现象,促进临床合理用药。
Objective: To compare the rationality of single intravenous drug administration before and after the establishment of PIVAS. Methods: The long-term prescription for intravenous drug administration before PIVAS was established (January-December 2013) as group A, and the long-term prescription for intravenous drug administration as group B after PIVAS was established (from January to December 2015), to analyze the unreasonable defects of single prescription medication The reason for interfering with clinical unreasonable medication orders, prompting clinical rational use of medicine. Results: In group A, there were 117 381 groups (each group transfused as one group), accounting for 20.67% of unreasonable medical orders; group B, 45 147, accounting for 8.06%. After the analysis, pharmacists conducted interventions in advance and corrected rate increased from 25.05% To 94.78%. Conclusion: PIVAS pharmacists did not audit their medical orders before they were implemented, and they intervened in a variety of ways to stop the irrational drug use and promote the rational use of drugs.